Maynard Um
-
-
-
-
-
-
-
Heron Therapeutics reports Q4 2025 revenue of $40.5 million
-
-
-
-
-
-
-
Heron Therapeutics (HRTX) Tops Q1 EPS by 3c
-
-
-
-
-
-
-
Heron Therapeutics (HRTX) Misses Q2 EPS by 2c, provides guidance
439,923 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

